Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Opioid-Related Disorders | 98 | 2024 | 2164 | 11.480 |
Why?
|
Substance-Related Disorders | 154 | 2024 | 4414 | 10.590 |
Why?
|
Buprenorphine | 38 | 2024 | 656 | 7.720 |
Why?
|
Alcoholism | 53 | 2020 | 1973 | 4.550 |
Why?
|
Opiate Substitution Treatment | 23 | 2024 | 444 | 4.180 |
Why?
|
Narcotic Antagonists | 29 | 2024 | 585 | 3.990 |
Why?
|
Analgesics, Opioid | 54 | 2024 | 3808 | 3.720 |
Why?
|
Naloxone | 18 | 2024 | 370 | 3.650 |
Why?
|
Cocaine-Related Disorders | 33 | 2020 | 461 | 3.550 |
Why?
|
Bipolar Disorder | 48 | 2019 | 5091 | 3.310 |
Why?
|
Cocaine | 31 | 2023 | 958 | 2.800 |
Why?
|
Psychotherapy | 21 | 2020 | 1646 | 2.130 |
Why?
|
Diagnosis, Dual (Psychiatry) | 39 | 2016 | 303 | 2.120 |
Why?
|
Psychotherapy, Group | 20 | 2021 | 413 | 2.020 |
Why?
|
Naltrexone | 12 | 2024 | 317 | 1.660 |
Why?
|
Heroin Dependence | 9 | 2017 | 172 | 1.530 |
Why?
|
Anxiety Disorders | 17 | 2024 | 2723 | 1.520 |
Why?
|
Substance Withdrawal Syndrome | 15 | 2018 | 624 | 1.500 |
Why?
|
Self-Help Groups | 10 | 2019 | 192 | 1.480 |
Why?
|
Alcohol-Related Disorders | 8 | 2016 | 238 | 1.440 |
Why?
|
Prescription Drugs | 10 | 2014 | 631 | 1.400 |
Why?
|
Counseling | 18 | 2021 | 1536 | 1.370 |
Why?
|
Behavior Therapy | 10 | 2024 | 875 | 1.360 |
Why?
|
Benzodiazepines | 8 | 2022 | 1134 | 1.290 |
Why?
|
Marijuana Abuse | 11 | 2020 | 410 | 1.290 |
Why?
|
Adult | 209 | 2024 | 221083 | 1.180 |
Why?
|
Cognition Disorders | 9 | 2012 | 3974 | 1.170 |
Why?
|
Substance Abuse Treatment Centers | 10 | 2014 | 166 | 1.160 |
Why?
|
Endocarditis | 3 | 2020 | 349 | 1.150 |
Why?
|
Substance Abuse Detection | 11 | 2014 | 301 | 1.140 |
Why?
|
Alcohol Deterrents | 7 | 2016 | 49 | 1.080 |
Why?
|
Humans | 325 | 2024 | 761098 | 0.990 |
Why?
|
Male | 221 | 2024 | 360675 | 0.950 |
Why?
|
Clinical Trials as Topic | 14 | 2023 | 8000 | 0.950 |
Why?
|
Sex Offenses | 3 | 2020 | 352 | 0.920 |
Why?
|
Stress Disorders, Post-Traumatic | 18 | 2021 | 4575 | 0.920 |
Why?
|
Female | 223 | 2024 | 392458 | 0.910 |
Why?
|
Patient Compliance | 10 | 2020 | 2687 | 0.880 |
Why?
|
Catastrophization | 4 | 2020 | 349 | 0.880 |
Why?
|
Cannabis | 3 | 2021 | 441 | 0.870 |
Why?
|
Affect | 7 | 2013 | 1486 | 0.860 |
Why?
|
Research Design | 15 | 2024 | 6178 | 0.830 |
Why?
|
Psychiatric Status Rating Scales | 35 | 2016 | 6011 | 0.830 |
Why?
|
Pharmaceutical Preparations | 2 | 2021 | 1086 | 0.820 |
Why?
|
Delayed-Action Preparations | 4 | 2024 | 961 | 0.780 |
Why?
|
Anxiety | 12 | 2023 | 4572 | 0.780 |
Why?
|
Methamphetamine | 1 | 2023 | 165 | 0.770 |
Why?
|
Central Nervous System Stimulants | 4 | 2023 | 1176 | 0.770 |
Why?
|
Comorbidity | 42 | 2019 | 10514 | 0.760 |
Why?
|
Depressive Disorder | 15 | 2019 | 3727 | 0.750 |
Why?
|
Narcotics | 5 | 2013 | 336 | 0.740 |
Why?
|
Treatment Refusal | 2 | 2020 | 429 | 0.730 |
Why?
|
Pain | 14 | 2023 | 5070 | 0.720 |
Why?
|
Receptors, Opioid, mu | 2 | 2021 | 167 | 0.710 |
Why?
|
Unsafe Sex | 3 | 2013 | 238 | 0.700 |
Why?
|
Cues | 3 | 2016 | 875 | 0.700 |
Why?
|
Heroin | 6 | 2024 | 119 | 0.690 |
Why?
|
Motivation | 11 | 2022 | 2003 | 0.690 |
Why?
|
Behavior, Addictive | 5 | 2015 | 462 | 0.690 |
Why?
|
Personal Satisfaction | 2 | 2023 | 645 | 0.660 |
Why?
|
Societies, Scientific | 1 | 2020 | 223 | 0.650 |
Why?
|
Patient Acceptance of Health Care | 8 | 2015 | 3197 | 0.650 |
Why?
|
Substance Abuse, Intravenous | 3 | 2020 | 529 | 0.650 |
Why?
|
Community Mental Health Services | 3 | 2011 | 387 | 0.640 |
Why?
|
Models, Statistical | 4 | 2023 | 5077 | 0.640 |
Why?
|
Psychotropic Drugs | 7 | 2012 | 885 | 0.630 |
Why?
|
Cannabinoids | 1 | 2021 | 172 | 0.620 |
Why?
|
Mood Disorders | 11 | 2019 | 1124 | 0.600 |
Why?
|
Psychiatry | 3 | 2020 | 1692 | 0.590 |
Why?
|
Young Adult | 50 | 2024 | 59199 | 0.590 |
Why?
|
Self Report | 11 | 2024 | 3728 | 0.590 |
Why?
|
Middle Aged | 102 | 2024 | 220835 | 0.590 |
Why?
|
Treatment Outcome | 54 | 2024 | 64670 | 0.580 |
Why?
|
Tobacco Use Disorder | 7 | 2024 | 703 | 0.580 |
Why?
|
Combined Modality Therapy | 25 | 2017 | 8519 | 0.580 |
Why?
|
Psychometrics | 17 | 2023 | 3061 | 0.580 |
Why?
|
Oxycodone | 3 | 2022 | 139 | 0.560 |
Why?
|
Psychotic Disorders | 8 | 2022 | 3219 | 0.550 |
Why?
|
Linear Models | 3 | 2023 | 5869 | 0.550 |
Why?
|
Legislation, Medical | 1 | 2017 | 98 | 0.550 |
Why?
|
Taurine | 6 | 2016 | 92 | 0.540 |
Why?
|
Anniversaries and Special Events | 1 | 2017 | 95 | 0.530 |
Why?
|
Neuropsychological Tests | 10 | 2013 | 7043 | 0.530 |
Why?
|
Drug Prescriptions | 5 | 2022 | 1669 | 0.520 |
Why?
|
Ambulatory Care | 12 | 2023 | 2769 | 0.510 |
Why?
|
Irritable Mood | 1 | 2016 | 193 | 0.500 |
Why?
|
Mental Disorders | 17 | 2019 | 6818 | 0.500 |
Why?
|
Community Mental Health Centers | 2 | 2013 | 93 | 0.490 |
Why?
|
Self Medication | 5 | 2013 | 117 | 0.490 |
Why?
|
Child Abuse | 6 | 2020 | 1076 | 0.480 |
Why?
|
Smoking Cessation | 5 | 2016 | 2057 | 0.480 |
Why?
|
Pain Measurement | 7 | 2019 | 3548 | 0.480 |
Why?
|
Social Support | 5 | 2011 | 2175 | 0.480 |
Why?
|
Endpoint Determination | 1 | 2017 | 590 | 0.480 |
Why?
|
Urinalysis | 2 | 2014 | 368 | 0.470 |
Why?
|
Inpatients | 3 | 2023 | 2545 | 0.470 |
Why?
|
Longitudinal Studies | 17 | 2023 | 14607 | 0.470 |
Why?
|
Severity of Illness Index | 23 | 2019 | 15845 | 0.470 |
Why?
|
Secondary Prevention | 7 | 2023 | 1472 | 0.450 |
Why?
|
Patient Dropouts | 5 | 2020 | 411 | 0.450 |
Why?
|
Prevalence | 16 | 2023 | 15717 | 0.440 |
Why?
|
Methadone | 7 | 2023 | 321 | 0.440 |
Why?
|
Residential Treatment | 2 | 2011 | 111 | 0.440 |
Why?
|
Domestic Violence | 4 | 2009 | 180 | 0.440 |
Why?
|
Restless Legs Syndrome | 1 | 2016 | 233 | 0.440 |
Why?
|
Hospitalization | 20 | 2020 | 10712 | 0.440 |
Why?
|
Adolescent | 54 | 2024 | 88271 | 0.440 |
Why?
|
Follow-Up Studies | 28 | 2020 | 39121 | 0.430 |
Why?
|
Token Economy | 1 | 2013 | 17 | 0.430 |
Why?
|
Patient Discharge | 4 | 2020 | 3441 | 0.430 |
Why?
|
Pilot Projects | 13 | 2024 | 8639 | 0.420 |
Why?
|
Depression | 7 | 2019 | 8130 | 0.420 |
Why?
|
Social Adjustment | 2 | 2013 | 632 | 0.420 |
Why?
|
Alcoholics Anonymous | 5 | 2008 | 33 | 0.400 |
Why?
|
United States | 45 | 2024 | 72337 | 0.400 |
Why?
|
Disabled Persons | 1 | 2022 | 1226 | 0.400 |
Why?
|
Adaptation, Psychological | 6 | 2022 | 2632 | 0.390 |
Why?
|
Job Application | 1 | 2011 | 38 | 0.380 |
Why?
|
Nicotine | 4 | 2023 | 678 | 0.380 |
Why?
|
Chi-Square Distribution | 8 | 2023 | 3419 | 0.380 |
Why?
|
Personality Inventory | 6 | 2007 | 1017 | 0.370 |
Why?
|
Suicide | 1 | 2022 | 1601 | 0.360 |
Why?
|
Patient Care Management | 1 | 2014 | 302 | 0.360 |
Why?
|
Randomized Controlled Trials as Topic | 13 | 2020 | 10213 | 0.360 |
Why?
|
Public Policy | 1 | 2014 | 557 | 0.350 |
Why?
|
Sleep Disorders, Circadian Rhythm | 1 | 2012 | 196 | 0.340 |
Why?
|
Risk-Taking | 3 | 2011 | 1038 | 0.340 |
Why?
|
Attitude to Health | 4 | 2016 | 2024 | 0.340 |
Why?
|
Outpatients | 6 | 2021 | 1596 | 0.340 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 11 | 2024 | 1988 | 0.330 |
Why?
|
Euphoria | 2 | 2008 | 65 | 0.330 |
Why?
|
Sex Factors | 15 | 2023 | 10552 | 0.320 |
Why?
|
Temperance | 6 | 2015 | 87 | 0.320 |
Why?
|
Acupuncture Points | 1 | 2009 | 111 | 0.320 |
Why?
|
Patient Preference | 2 | 2016 | 926 | 0.310 |
Why?
|
Suicide, Attempted | 8 | 2019 | 1402 | 0.310 |
Why?
|
Cognition | 4 | 2023 | 6987 | 0.300 |
Why?
|
Education | 1 | 2011 | 535 | 0.300 |
Why?
|
Affective Disorders, Psychotic | 1 | 2009 | 186 | 0.300 |
Why?
|
Recurrence | 16 | 2016 | 8456 | 0.300 |
Why?
|
Genetic Linkage | 6 | 2010 | 2340 | 0.290 |
Why?
|
Alcohol Drinking | 5 | 2016 | 4028 | 0.290 |
Why?
|
Reproducibility of Results | 17 | 2023 | 20120 | 0.290 |
Why?
|
Disulfiram | 2 | 2020 | 63 | 0.290 |
Why?
|
National Institute on Drug Abuse (U.S.) | 6 | 2014 | 11 | 0.290 |
Why?
|
Cross-Sectional Studies | 20 | 2023 | 26068 | 0.280 |
Why?
|
Feasibility Studies | 7 | 2024 | 5249 | 0.280 |
Why?
|
Transcutaneous Electric Nerve Stimulation | 1 | 2009 | 170 | 0.280 |
Why?
|
Withholding Treatment | 2 | 2024 | 616 | 0.280 |
Why?
|
Paranoid Disorders | 5 | 2011 | 61 | 0.280 |
Why?
|
Sleep Initiation and Maintenance Disorders | 3 | 2018 | 1081 | 0.280 |
Why?
|
Risk | 4 | 2016 | 9614 | 0.270 |
Why?
|
Hypnotics and Sedatives | 4 | 2018 | 1178 | 0.270 |
Why?
|
Chemistry, Pharmaceutical | 1 | 2007 | 274 | 0.270 |
Why?
|
N-Methyl-3,4-methylenedioxyamphetamine | 2 | 2009 | 65 | 0.270 |
Why?
|
Antipsychotic Agents | 5 | 2011 | 3063 | 0.270 |
Why?
|
Deception | 1 | 2007 | 99 | 0.260 |
Why?
|
Sex Characteristics | 3 | 2020 | 2638 | 0.260 |
Why?
|
Adolescent Behavior | 3 | 2014 | 1188 | 0.260 |
Why?
|
Ecosystem | 1 | 2010 | 489 | 0.260 |
Why?
|
Periodicals as Topic | 1 | 2017 | 1463 | 0.260 |
Why?
|
Interview, Psychological | 6 | 2011 | 809 | 0.260 |
Why?
|
Administration, Sublingual | 2 | 2024 | 59 | 0.260 |
Why?
|
Executive Function | 5 | 2013 | 1388 | 0.250 |
Why?
|
Self Efficacy | 2 | 2019 | 636 | 0.250 |
Why?
|
Anti-Anxiety Agents | 3 | 2018 | 397 | 0.250 |
Why?
|
Drug Therapy | 2 | 2005 | 503 | 0.250 |
Why?
|
Employment | 2 | 2011 | 1114 | 0.240 |
Why?
|
Massachusetts | 13 | 2020 | 8836 | 0.240 |
Why?
|
Sexual Behavior | 2 | 2011 | 2189 | 0.240 |
Why?
|
Likelihood Functions | 2 | 2023 | 991 | 0.230 |
Why?
|
Medication Adherence | 3 | 2011 | 2175 | 0.230 |
Why?
|
Multicenter Studies as Topic | 3 | 2018 | 1702 | 0.230 |
Why?
|
Information Services | 1 | 2005 | 236 | 0.230 |
Why?
|
Attention | 6 | 2013 | 2394 | 0.220 |
Why?
|
Lithium | 2 | 1998 | 596 | 0.220 |
Why?
|
Patient Selection | 5 | 2011 | 4245 | 0.220 |
Why?
|
Drug Therapy, Combination | 6 | 2016 | 6305 | 0.220 |
Why?
|
Hallucinogens | 2 | 2009 | 197 | 0.210 |
Why?
|
Primary Health Care | 7 | 2022 | 4673 | 0.210 |
Why?
|
Borderline Personality Disorder | 1 | 2010 | 766 | 0.210 |
Why?
|
Antidepressive Agents | 2 | 2012 | 2893 | 0.210 |
Why?
|
Mass Screening | 6 | 2023 | 5425 | 0.210 |
Why?
|
Memory | 5 | 2013 | 2190 | 0.200 |
Why?
|
Hydrocodone | 1 | 2022 | 48 | 0.200 |
Why?
|
Patient Satisfaction | 3 | 2024 | 3450 | 0.200 |
Why?
|
District of Columbia | 1 | 2022 | 159 | 0.200 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2016 | 4013 | 0.200 |
Why?
|
Quality of Life | 8 | 2023 | 13362 | 0.200 |
Why?
|
Quality Assurance, Health Care | 2 | 2011 | 2165 | 0.200 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 6 | 2010 | 3707 | 0.200 |
Why?
|
Achievement | 1 | 2003 | 288 | 0.190 |
Why?
|
Emergency Service, Hospital | 3 | 2024 | 7873 | 0.190 |
Why?
|
Stress, Psychological | 2 | 2017 | 4488 | 0.190 |
Why?
|
Pregnancy Complications | 2 | 2015 | 2948 | 0.190 |
Why?
|
Patient Education as Topic | 4 | 2024 | 2316 | 0.190 |
Why?
|
Life Change Events | 4 | 2009 | 952 | 0.190 |
Why?
|
Hospitals, Psychiatric | 6 | 2017 | 318 | 0.190 |
Why?
|
Risk Factors | 23 | 2022 | 74219 | 0.180 |
Why?
|
Mental Health Services | 5 | 2019 | 1715 | 0.180 |
Why?
|
Remission, Spontaneous | 2 | 2012 | 384 | 0.180 |
Why?
|
Receptors, Serotonin | 1 | 2001 | 208 | 0.180 |
Why?
|
Patient Admission | 5 | 2008 | 1365 | 0.180 |
Why?
|
Pyridines | 1 | 2012 | 2872 | 0.180 |
Why?
|
Health Status | 6 | 2015 | 4077 | 0.180 |
Why?
|
Drug Users | 2 | 2020 | 134 | 0.180 |
Why?
|
Multivariate Analysis | 6 | 2013 | 12058 | 0.180 |
Why?
|
Computer Simulation | 3 | 2023 | 6225 | 0.170 |
Why?
|
Time Factors | 11 | 2019 | 39953 | 0.170 |
Why?
|
Socioeconomic Factors | 8 | 2015 | 7804 | 0.170 |
Why?
|
Self-Injurious Behavior | 1 | 2006 | 566 | 0.170 |
Why?
|
Normal Distribution | 1 | 2020 | 272 | 0.170 |
Why?
|
Drive | 1 | 2019 | 34 | 0.170 |
Why?
|
Referral and Consultation | 4 | 2015 | 3603 | 0.170 |
Why?
|
Crime | 3 | 2018 | 204 | 0.170 |
Why?
|
Comprehension | 1 | 2005 | 619 | 0.170 |
Why?
|
Personality Disorders | 2 | 1995 | 719 | 0.170 |
Why?
|
Quality of Health Care | 2 | 2005 | 4319 | 0.170 |
Why?
|
Seizures | 1 | 2012 | 2965 | 0.170 |
Why?
|
Prognosis | 13 | 2019 | 29672 | 0.160 |
Why?
|
Aged | 23 | 2022 | 169266 | 0.160 |
Why?
|
Attitude of Health Personnel | 1 | 2013 | 3882 | 0.160 |
Why?
|
Chromosomes, Human, Pair 10 | 2 | 2010 | 277 | 0.160 |
Why?
|
Photic Stimulation | 2 | 2016 | 1984 | 0.150 |
Why?
|
Pain Threshold | 2 | 2016 | 603 | 0.150 |
Why?
|
Ethanol | 4 | 2023 | 1322 | 0.150 |
Why?
|
Odds Ratio | 4 | 2020 | 9648 | 0.150 |
Why?
|
Analysis of Variance | 5 | 2013 | 6224 | 0.150 |
Why?
|
Perception | 1 | 2004 | 1198 | 0.140 |
Why?
|
Data Interpretation, Statistical | 4 | 2013 | 2691 | 0.140 |
Why?
|
Factor Analysis, Statistical | 4 | 2021 | 998 | 0.140 |
Why?
|
Nursing Care | 1 | 2017 | 65 | 0.140 |
Why?
|
Risperidone | 1 | 1999 | 381 | 0.140 |
Why?
|
Spiritual Therapies | 1 | 2017 | 60 | 0.140 |
Why?
|
Practice Guidelines as Topic | 3 | 2017 | 7400 | 0.140 |
Why?
|
Injections | 1 | 2020 | 832 | 0.140 |
Why?
|
Logistic Models | 6 | 2020 | 13254 | 0.140 |
Why?
|
Case Management | 2 | 2019 | 272 | 0.140 |
Why?
|
Adult Survivors of Child Abuse | 1 | 2020 | 294 | 0.130 |
Why?
|
Electronic Prescribing | 1 | 2017 | 114 | 0.130 |
Why?
|
Medication Therapy Management | 1 | 2017 | 130 | 0.130 |
Why?
|
HIV Infections | 4 | 2013 | 17349 | 0.130 |
Why?
|
Long-Term Care | 2 | 2017 | 630 | 0.130 |
Why?
|
Patient Participation | 1 | 2005 | 1444 | 0.130 |
Why?
|
Prospective Studies | 11 | 2017 | 54419 | 0.130 |
Why?
|
Prejudice | 1 | 2019 | 572 | 0.120 |
Why?
|
Valproic Acid | 1 | 1998 | 443 | 0.120 |
Why?
|
Predictive Value of Tests | 7 | 2012 | 15308 | 0.120 |
Why?
|
Methylphenidate | 2 | 2010 | 488 | 0.120 |
Why?
|
Gonadal Steroid Hormones | 1 | 2019 | 702 | 0.120 |
Why?
|
Age Factors | 8 | 2019 | 18385 | 0.120 |
Why?
|
Smoking | 5 | 2020 | 9055 | 0.120 |
Why?
|
Pulmonary Diffusing Capacity | 2 | 1987 | 94 | 0.120 |
Why?
|
Intelligence | 2 | 2011 | 922 | 0.120 |
Why?
|
Telemedicine | 2 | 2022 | 3051 | 0.120 |
Why?
|
Universities | 1 | 2019 | 995 | 0.120 |
Why?
|
History, 21st Century | 1 | 2020 | 1566 | 0.110 |
Why?
|
Health Surveys | 3 | 2016 | 4036 | 0.110 |
Why?
|
Religion | 1 | 2017 | 376 | 0.110 |
Why?
|
Amphetamine-Related Disorders | 1 | 2014 | 80 | 0.110 |
Why?
|
Fructose | 1 | 2016 | 286 | 0.110 |
Why?
|
Professional-Patient Relations | 2 | 2001 | 722 | 0.110 |
Why?
|
Data Collection | 3 | 2013 | 3319 | 0.110 |
Why?
|
Retrospective Studies | 15 | 2023 | 80673 | 0.110 |
Why?
|
Managed Care Programs | 2 | 2013 | 937 | 0.110 |
Why?
|
Psychological Tests | 4 | 2007 | 639 | 0.110 |
Why?
|
Corpus Striatum | 1 | 2019 | 1235 | 0.110 |
Why?
|
Antimanic Agents | 2 | 2009 | 520 | 0.110 |
Why?
|
Sickness Impact Profile | 1 | 2014 | 299 | 0.110 |
Why?
|
Regression Analysis | 5 | 2013 | 6343 | 0.110 |
Why?
|
Acetylcysteine | 1 | 2014 | 260 | 0.110 |
Why?
|
Memory, Short-Term | 2 | 2011 | 982 | 0.110 |
Why?
|
Suicidal Ideation | 2 | 2022 | 1447 | 0.110 |
Why?
|
Self Concept | 2 | 2018 | 1046 | 0.110 |
Why?
|
Anticonvulsants | 2 | 2018 | 1911 | 0.100 |
Why?
|
Dreams | 1 | 2014 | 146 | 0.100 |
Why?
|
Diagnosis, Differential | 5 | 2012 | 12975 | 0.100 |
Why?
|
Survivors | 2 | 2022 | 2369 | 0.100 |
Why?
|
Schizophrenia | 3 | 2007 | 6929 | 0.100 |
Why?
|
History, 20th Century | 1 | 2020 | 2764 | 0.100 |
Why?
|
Therapeutic Community | 1 | 2011 | 20 | 0.100 |
Why?
|
Catechol O-Methyltransferase | 2 | 2011 | 251 | 0.100 |
Why?
|
Sexual Partners | 2 | 2009 | 800 | 0.100 |
Why?
|
Community Health Services | 3 | 2011 | 654 | 0.100 |
Why?
|
Prolactin | 1 | 1994 | 625 | 0.100 |
Why?
|
Desipramine | 2 | 1989 | 182 | 0.100 |
Why?
|
Haplotypes | 5 | 2011 | 2714 | 0.100 |
Why?
|
Polymorphism, Single Nucleotide | 9 | 2011 | 15915 | 0.090 |
Why?
|
Statistics as Topic | 2 | 2008 | 2359 | 0.090 |
Why?
|
Chronic Disease | 5 | 2009 | 9317 | 0.090 |
Why?
|
Models, Psychological | 1 | 2015 | 828 | 0.090 |
Why?
|
Depressive Disorder, Major | 4 | 2019 | 4766 | 0.090 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2013 | 10755 | 0.090 |
Why?
|
Gene Frequency | 8 | 2010 | 3603 | 0.090 |
Why?
|
Confidence Intervals | 2 | 2009 | 2927 | 0.090 |
Why?
|
Manuals as Topic | 3 | 2000 | 99 | 0.090 |
Why?
|
Alcohol-Induced Disorders, Nervous System | 1 | 2010 | 13 | 0.090 |
Why?
|
Drug Administration Schedule | 2 | 2009 | 4849 | 0.090 |
Why?
|
Reading | 1 | 2014 | 531 | 0.090 |
Why?
|
Health Care Surveys | 2 | 2021 | 2424 | 0.090 |
Why?
|
Biomedical Research | 2 | 2020 | 3429 | 0.090 |
Why?
|
Cause of Death | 1 | 2020 | 3688 | 0.080 |
Why?
|
Milieu Therapy | 1 | 1989 | 3 | 0.080 |
Why?
|
Mannosidases | 1 | 2009 | 21 | 0.080 |
Why?
|
Vermont | 1 | 2009 | 81 | 0.080 |
Why?
|
United States Food and Drug Administration | 1 | 2017 | 1661 | 0.080 |
Why?
|
Gender Identity | 1 | 2015 | 765 | 0.080 |
Why?
|
Guideline Adherence | 2 | 2017 | 2218 | 0.080 |
Why?
|
Personality Assessment | 4 | 2006 | 649 | 0.080 |
Why?
|
New Hampshire | 1 | 2009 | 175 | 0.080 |
Why?
|
Negativism | 1 | 2008 | 23 | 0.080 |
Why?
|
Fentanyl | 2 | 2024 | 433 | 0.080 |
Why?
|
Cyclothymic Disorder | 2 | 2004 | 42 | 0.080 |
Why?
|
Pro-Opiomelanocortin | 1 | 2009 | 140 | 0.080 |
Why?
|
Goals | 3 | 2009 | 708 | 0.080 |
Why?
|
Directive Counseling | 1 | 2010 | 170 | 0.080 |
Why?
|
Health Literacy | 1 | 2014 | 443 | 0.080 |
Why?
|
Psychology | 1 | 2010 | 356 | 0.080 |
Why?
|
Aftercare | 2 | 2008 | 913 | 0.080 |
Why?
|
Carbon Monoxide | 2 | 2013 | 547 | 0.080 |
Why?
|
Proportional Hazards Models | 5 | 2022 | 12467 | 0.070 |
Why?
|
Receptor, Cannabinoid, CB1 | 1 | 2008 | 137 | 0.070 |
Why?
|
Serotonin Plasma Membrane Transport Proteins | 1 | 2009 | 325 | 0.070 |
Why?
|
Genetic Predisposition to Disease | 8 | 2011 | 17889 | 0.070 |
Why?
|
Health Services Accessibility | 2 | 2024 | 5427 | 0.070 |
Why?
|
Mental Health | 3 | 2024 | 3251 | 0.070 |
Why?
|
Length of Stay | 4 | 2008 | 6420 | 0.070 |
Why?
|
Chromosome Mapping | 4 | 2010 | 4612 | 0.070 |
Why?
|
Triage | 1 | 2014 | 984 | 0.070 |
Why?
|
Social Work | 1 | 2009 | 157 | 0.070 |
Why?
|
Carbamazepine | 2 | 2018 | 224 | 0.070 |
Why?
|
Medical Assistance | 1 | 2008 | 108 | 0.070 |
Why?
|
Placebo Effect | 2 | 2008 | 518 | 0.070 |
Why?
|
Adolescent Development | 1 | 2010 | 282 | 0.070 |
Why?
|
Self-Assessment | 2 | 2000 | 399 | 0.070 |
Why?
|
Antidepressive Agents, Tricyclic | 1 | 1989 | 431 | 0.070 |
Why?
|
Receptors, GABA-A | 1 | 2011 | 621 | 0.070 |
Why?
|
Patient Care Team | 3 | 1995 | 2513 | 0.070 |
Why?
|
Cooperative Behavior | 1 | 2014 | 1505 | 0.070 |
Why?
|
Dopa Decarboxylase | 1 | 2006 | 14 | 0.070 |
Why?
|
Veterans | 1 | 2020 | 2652 | 0.070 |
Why?
|
Sensitivity and Specificity | 4 | 2023 | 14676 | 0.070 |
Why?
|
Neural Cell Adhesion Molecules | 1 | 2006 | 122 | 0.070 |
Why?
|
Nuclear Family | 4 | 2008 | 311 | 0.070 |
Why?
|
Social Behavior | 1 | 2013 | 1135 | 0.070 |
Why?
|
Child Abuse, Sexual | 3 | 1998 | 403 | 0.070 |
Why?
|
Genetic Variation | 4 | 2011 | 6565 | 0.070 |
Why?
|
Michigan | 1 | 2007 | 339 | 0.070 |
Why?
|
Patient Care Planning | 2 | 2008 | 904 | 0.060 |
Why?
|
Genotype | 9 | 2011 | 12983 | 0.060 |
Why?
|
Problem Solving | 1 | 2008 | 443 | 0.060 |
Why?
|
False Negative Reactions | 1 | 2007 | 573 | 0.060 |
Why?
|
Siblings | 2 | 2009 | 824 | 0.060 |
Why?
|
Pemoline | 1 | 1985 | 18 | 0.060 |
Why?
|
Cluster Analysis | 5 | 2008 | 2706 | 0.060 |
Why?
|
Antisocial Personality Disorder | 5 | 1997 | 224 | 0.060 |
Why?
|
Impulsive Behavior | 1 | 2008 | 346 | 0.060 |
Why?
|
Legislation, Drug | 1 | 2007 | 214 | 0.060 |
Why?
|
Double-Blind Method | 5 | 2016 | 12341 | 0.060 |
Why?
|
Child | 11 | 2024 | 80134 | 0.060 |
Why?
|
Chromosomes, Human, Pair 5 | 1 | 2006 | 386 | 0.060 |
Why?
|
Terminology as Topic | 2 | 2013 | 1528 | 0.060 |
Why?
|
Chromosomes, Human, Pair 17 | 1 | 2006 | 418 | 0.060 |
Why?
|
Health Status Indicators | 1 | 2010 | 970 | 0.060 |
Why?
|
Drug Discovery | 1 | 2012 | 1049 | 0.060 |
Why?
|
Receptors, Dopamine D2 | 1 | 2006 | 485 | 0.060 |
Why?
|
Medical Records | 2 | 2012 | 1409 | 0.060 |
Why?
|
Pregnancy | 3 | 2015 | 29872 | 0.060 |
Why?
|
Demography | 2 | 2006 | 1643 | 0.060 |
Why?
|
Interviews as Topic | 1 | 2011 | 2696 | 0.060 |
Why?
|
Genome, Human | 2 | 2008 | 4423 | 0.060 |
Why?
|
Probability | 2 | 2023 | 2478 | 0.050 |
Why?
|
Linkage Disequilibrium | 4 | 2011 | 1995 | 0.050 |
Why?
|
Immunoassay | 1 | 2007 | 743 | 0.050 |
Why?
|
Disability Evaluation | 1 | 2010 | 1834 | 0.050 |
Why?
|
Evidence-Based Medicine | 2 | 2005 | 3689 | 0.050 |
Why?
|
Administration, Cutaneous | 2 | 2013 | 713 | 0.050 |
Why?
|
Sick Role | 1 | 2003 | 229 | 0.050 |
Why?
|
Negotiating | 1 | 2003 | 151 | 0.050 |
Why?
|
Central Nervous System Depressants | 3 | 1988 | 164 | 0.050 |
Why?
|
Cohort Studies | 5 | 2023 | 41486 | 0.050 |
Why?
|
Medicaid | 3 | 2024 | 2814 | 0.050 |
Why?
|
Oregon | 1 | 2022 | 147 | 0.050 |
Why?
|
Malignant Hyperthermia | 1 | 2001 | 71 | 0.050 |
Why?
|
ROC Curve | 1 | 2009 | 3582 | 0.050 |
Why?
|
Consensus | 2 | 2022 | 3133 | 0.050 |
Why?
|
Quantitative Trait Loci | 2 | 2008 | 2113 | 0.050 |
Why?
|
Pandemics | 1 | 2021 | 8663 | 0.050 |
Why?
|
Survival Analysis | 3 | 2009 | 10083 | 0.050 |
Why?
|
Nitrosamines | 1 | 2021 | 87 | 0.050 |
Why?
|
Drug Interactions | 1 | 2005 | 1417 | 0.050 |
Why?
|
Guidelines as Topic | 1 | 2007 | 1386 | 0.040 |
Why?
|
Anabolic Agents | 1 | 2003 | 256 | 0.040 |
Why?
|
Age of Onset | 4 | 2009 | 3307 | 0.040 |
Why?
|
Kaplan-Meier Estimate | 1 | 2010 | 6482 | 0.040 |
Why?
|
Prescriptions | 1 | 2022 | 386 | 0.040 |
Why?
|
Waiting Lists | 1 | 2024 | 765 | 0.040 |
Why?
|
Disease Progression | 2 | 2019 | 13506 | 0.040 |
Why?
|
Delphi Technique | 1 | 2022 | 849 | 0.040 |
Why?
|
Reimbursement, Incentive | 1 | 2003 | 542 | 0.040 |
Why?
|
Sex Reassignment Procedures | 1 | 2019 | 70 | 0.040 |
Why?
|
Crack Cocaine | 1 | 1998 | 32 | 0.040 |
Why?
|
Bulimia | 2 | 1992 | 400 | 0.040 |
Why?
|
Acetaminophen | 1 | 2022 | 555 | 0.040 |
Why?
|
Social Environment | 2 | 2009 | 1021 | 0.040 |
Why?
|
Cost-Benefit Analysis | 2 | 2015 | 5494 | 0.040 |
Why?
|
Hospitals, Private | 1 | 2017 | 63 | 0.040 |
Why?
|
Urban Population | 2 | 2019 | 2035 | 0.030 |
Why?
|
Population Surveillance | 1 | 2007 | 2599 | 0.030 |
Why?
|
Risk Assessment | 4 | 2014 | 24013 | 0.030 |
Why?
|
Disease | 1 | 2002 | 670 | 0.030 |
Why?
|
Parents | 1 | 2010 | 3564 | 0.030 |
Why?
|
Interpersonal Relations | 1 | 2004 | 1437 | 0.030 |
Why?
|
Patient Readmission | 2 | 2004 | 3268 | 0.030 |
Why?
|
Pedigree | 4 | 2008 | 4537 | 0.030 |
Why?
|
Rehabilitation, Vocational | 1 | 1996 | 74 | 0.030 |
Why?
|
Self Care | 2 | 1999 | 795 | 0.030 |
Why?
|
Lod Score | 2 | 2006 | 600 | 0.030 |
Why?
|
Educational Status | 1 | 2003 | 2510 | 0.030 |
Why?
|
United States Department of Veterans Affairs | 1 | 2020 | 928 | 0.030 |
Why?
|
Psychophysics | 1 | 2016 | 291 | 0.030 |
Why?
|
Aging | 1 | 2014 | 8701 | 0.030 |
Why?
|
Physician-Patient Relations | 2 | 2006 | 3238 | 0.030 |
Why?
|
Organ Size | 1 | 2019 | 2253 | 0.030 |
Why?
|
Pain Perception | 1 | 2016 | 196 | 0.030 |
Why?
|
Physicians | 1 | 2012 | 4583 | 0.030 |
Why?
|
Acyltransferases | 1 | 1996 | 305 | 0.030 |
Why?
|
Age Distribution | 1 | 2000 | 2873 | 0.030 |
Why?
|
Drug Combinations | 2 | 2010 | 2048 | 0.030 |
Why?
|
Lung Volume Measurements | 2 | 1987 | 375 | 0.030 |
Why?
|
Statistics, Nonparametric | 2 | 2012 | 2855 | 0.030 |
Why?
|
Brain | 3 | 2010 | 27097 | 0.030 |
Why?
|
Cotinine | 1 | 2013 | 206 | 0.030 |
Why?
|
Internship and Residency | 1 | 2012 | 5879 | 0.020 |
Why?
|
Accidents | 1 | 2013 | 165 | 0.020 |
Why?
|
Neurologic Examination | 1 | 1995 | 915 | 0.020 |
Why?
|
Alleles | 3 | 2009 | 6857 | 0.020 |
Why?
|
Hyperalgesia | 1 | 2016 | 526 | 0.020 |
Why?
|
Health Policy | 1 | 2004 | 2680 | 0.020 |
Why?
|
Case-Control Studies | 4 | 2011 | 22157 | 0.020 |
Why?
|
Phenotype | 5 | 2007 | 16572 | 0.020 |
Why?
|
Cost Control | 1 | 2013 | 627 | 0.020 |
Why?
|
Adverse Drug Reaction Reporting Systems | 1 | 2013 | 494 | 0.020 |
Why?
|
Clinical Competence | 1 | 2005 | 4786 | 0.020 |
Why?
|
Risk Management | 1 | 2013 | 557 | 0.020 |
Why?
|
Neuroprotective Agents | 1 | 2016 | 956 | 0.020 |
Why?
|
Phencyclidine Abuse | 1 | 1988 | 8 | 0.020 |
Why?
|
National Institute on Alcohol Abuse and Alcoholism (U.S.) | 1 | 2008 | 10 | 0.020 |
Why?
|
Population | 1 | 2009 | 141 | 0.020 |
Why?
|
Norepinephrine | 1 | 2011 | 898 | 0.020 |
Why?
|
Cerebral Ventricles | 1 | 1991 | 542 | 0.020 |
Why?
|
Penetrance | 1 | 2010 | 382 | 0.020 |
Why?
|
Gas Chromatography-Mass Spectrometry | 1 | 1988 | 353 | 0.020 |
Why?
|
Leukocytes | 1 | 1996 | 2024 | 0.020 |
Why?
|
Chromosomes, Human, Pair 2 | 1 | 2009 | 313 | 0.020 |
Why?
|
Algorithms | 2 | 2005 | 14023 | 0.020 |
Why?
|
Family | 2 | 2009 | 3193 | 0.020 |
Why?
|
Computational Biology | 1 | 2019 | 3499 | 0.020 |
Why?
|
Amphetamine | 1 | 1988 | 224 | 0.020 |
Why?
|
Family Relations | 1 | 2009 | 315 | 0.020 |
Why?
|
Child of Impaired Parents | 1 | 1991 | 460 | 0.020 |
Why?
|
Medication Errors | 1 | 2013 | 783 | 0.020 |
Why?
|
Utilization Review | 1 | 2008 | 382 | 0.020 |
Why?
|
Narcissism | 1 | 1986 | 64 | 0.020 |
Why?
|
Registries | 1 | 2022 | 8236 | 0.020 |
Why?
|
Mixed Function Oxygenases | 1 | 2006 | 265 | 0.020 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2023 | 9278 | 0.020 |
Why?
|
Chromosomes, Human, Pair 3 | 1 | 2006 | 322 | 0.020 |
Why?
|
Chromosomes, Human, Pair 11 | 1 | 2006 | 410 | 0.010 |
Why?
|
Homozygote | 1 | 2009 | 1775 | 0.010 |
Why?
|
National Institutes of Health (U.S.) | 2 | 1999 | 793 | 0.010 |
Why?
|
Agoraphobia | 1 | 2004 | 177 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 2014 | 6817 | 0.010 |
Why?
|
Placebos | 1 | 2008 | 1666 | 0.010 |
Why?
|
Dopamine | 1 | 2011 | 1606 | 0.010 |
Why?
|
Cost Allocation | 1 | 2003 | 48 | 0.010 |
Why?
|
Language | 1 | 2013 | 1538 | 0.010 |
Why?
|
Introns | 1 | 2006 | 968 | 0.010 |
Why?
|
Multienzyme Complexes | 1 | 2006 | 665 | 0.010 |
Why?
|
Microsatellite Repeats | 1 | 2005 | 782 | 0.010 |
Why?
|
Arousal | 1 | 1989 | 1171 | 0.010 |
Why?
|
Genetic Markers | 1 | 2009 | 2599 | 0.010 |
Why?
|
Anorexia Nervosa | 1 | 1992 | 1361 | 0.010 |
Why?
|
Mental Recall | 1 | 1989 | 1221 | 0.010 |
Why?
|
Amygdala | 1 | 2010 | 1354 | 0.010 |
Why?
|
Syndrome | 1 | 1988 | 3269 | 0.010 |
Why?
|
Administration, Oral | 1 | 2010 | 4014 | 0.010 |
Why?
|
Emergency Medical Services | 1 | 2013 | 1921 | 0.010 |
Why?
|
Epidemiologic Methods | 1 | 2006 | 1336 | 0.010 |
Why?
|
Genetic Testing | 1 | 2014 | 3536 | 0.010 |
Why?
|
Panic Disorder | 1 | 2004 | 613 | 0.010 |
Why?
|
Psychotherapeutic Processes | 1 | 2001 | 51 | 0.010 |
Why?
|
Delivery of Health Care | 1 | 2019 | 5333 | 0.010 |
Why?
|
Family Health | 1 | 2005 | 1255 | 0.010 |
Why?
|
Schizophrenic Psychology | 1 | 2007 | 1644 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2009 | 6067 | 0.010 |
Why?
|
Neural Pathways | 1 | 2010 | 3057 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 2009 | 4243 | 0.010 |
Why?
|
Students | 1 | 2009 | 1737 | 0.010 |
Why?
|
Academic Medical Centers | 1 | 2009 | 2757 | 0.010 |
Why?
|
Nerve Net | 1 | 2010 | 2290 | 0.010 |
Why?
|
Aggression | 1 | 2003 | 748 | 0.010 |
Why?
|
Oxygen | 2 | 1998 | 4226 | 0.010 |
Why?
|
DNA | 1 | 2011 | 7189 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2008 | 4739 | 0.010 |
Why?
|
Bayes Theorem | 1 | 2005 | 2327 | 0.010 |
Why?
|
Random Allocation | 1 | 2001 | 2393 | 0.010 |
Why?
|
Carbon Dioxide | 1 | 1981 | 1148 | 0.010 |
Why?
|
Gene Expression | 1 | 2009 | 7567 | 0.010 |
Why?
|
Animals | 1 | 2007 | 168083 | 0.010 |
Why?
|
Models, Genetic | 1 | 2005 | 3430 | 0.010 |
Why?
|
Lymphocyte Subsets | 1 | 1996 | 312 | 0.010 |
Why?
|
Basal Ganglia | 1 | 1998 | 554 | 0.010 |
Why?
|
Combat Disorders | 1 | 1997 | 301 | 0.010 |
Why?
|
Tomography, Emission-Computed | 1 | 1998 | 1123 | 0.010 |
Why?
|
Regional Blood Flow | 1 | 1998 | 1498 | 0.010 |
Why?
|
Internal-External Control | 1 | 1996 | 358 | 0.010 |
Why?
|
Electroencephalography | 1 | 1989 | 6242 | 0.010 |
Why?
|
Recovery of Function | 1 | 2003 | 2981 | 0.010 |
Why?
|
Parietal Lobe | 1 | 1998 | 852 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 2 | 1998 | 36418 | 0.010 |
Why?
|
Incidence | 2 | 2006 | 21357 | 0.010 |
Why?
|
Clinical Protocols | 1 | 1997 | 1436 | 0.010 |
Why?
|
Health Personnel | 1 | 2005 | 3335 | 0.010 |
Why?
|
Gyrus Cinguli | 1 | 1998 | 1114 | 0.010 |
Why?
|
Health Expenditures | 1 | 2003 | 2363 | 0.010 |
Why?
|
Poisson Distribution | 1 | 1992 | 504 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2010 | 12670 | 0.010 |
Why?
|
Temporal Lobe | 1 | 1998 | 1695 | 0.010 |
Why?
|
Enzyme Activation | 1 | 1996 | 3577 | 0.010 |
Why?
|
Marriage | 1 | 1992 | 349 | 0.010 |
Why?
|
Personality Tests | 1 | 1989 | 80 | 0.010 |
Why?
|
Reference Values | 1 | 1996 | 4922 | 0.000 |
Why?
|
Methoxyhydroxyphenylglycol | 1 | 1988 | 93 | 0.000 |
Why?
|
Fatty Acids | 1 | 1996 | 1806 | 0.000 |
Why?
|
Monoamine Oxidase | 1 | 1988 | 181 | 0.000 |
Why?
|
Prefrontal Cortex | 1 | 1998 | 2219 | 0.000 |
Why?
|
Evoked Potentials, Auditory | 1 | 1989 | 531 | 0.000 |
Why?
|
Child, Preschool | 1 | 2008 | 42217 | 0.000 |
Why?
|
Job Satisfaction | 1 | 1989 | 545 | 0.000 |
Why?
|
Aged, 80 and over | 1 | 2009 | 58946 | 0.000 |
Why?
|
Reaction Time | 1 | 1989 | 2087 | 0.000 |
Why?
|
Blood Platelets | 1 | 1988 | 2477 | 0.000 |
Why?
|